I.Ceram Stock price

Equities

ALICR

FR0014005IU4

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 12:00:03 2024-03-28 pm EDT 5-day change 1st Jan Change
1.3 EUR 0.00% Intraday chart for I.Ceram -15.58% -55.17%
Sales 2021 1.56M 1.68M Sales 2022 1.43M 1.54M Capitalization 2.99M 3.22M
Net income 2021 - 0 Net income 2022 - 0 EV / Sales 2021 4.44 x
Net Debt 2021 2.15M 2.31M Net Debt 2022 1.8M 1.94M EV / Sales 2022 3.35 x
P/E ratio 2021
-6.31 x
P/E ratio 2022
-3.18 x
Employees 25
Yield 2021 *
-
Yield 2022
-
Free-Float 45.7%
More Fundamentals * Assessed data
Dynamic Chart
1 week-15.58%
Current month-63.07%
1 month-64.67%
3 months-52.21%
6 months-58.06%
Current year-55.17%
More quotes
1 week
1.30
Extreme 1.3
1.44
1 month
1.30
Extreme 1.3
3.40
Current year
1.30
Extreme 1.3
6.70
1 year
1.30
Extreme 1.3
9.70
3 years
1.30
Extreme 1.3
38.60
5 years
1.30
Extreme 1.3
100.00
10 years
1.30
Extreme 1.3
239.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 05-12-19
Chief Tech/Sci/R&D Officer - 16-08-31
Members of the board TitleAgeSince
Director/Board Member 68 14-09-17
Director/Board Member 66 19-04-15
Director/Board Member 56 14-09-17
More insiders
Date Price Change Volume
24-03-28 1.3 0.00% 110
24-03-27 1.3 -0.76% 1,131
24-03-26 1.31 0.00% 42
24-03-25 1.31 -12.67% 1,386
24-03-22 1.5 -2.60% 519

Real-time Euronext Paris, March 28, 2024 at 12:00 pm EDT

More quotes
I.Ceram specializes in the design, manufacture and marketing of orthopedic implants (metal, polymer and ceramic implants in porous alumina). The group provides prostheses for shoulder, spine, hip, tibia, ankle and foot as well as for osteosynthetic applications. Net sales by source of income break down between sales of non-ceramic products (87%) and sales of ceramic products (13%). France accounts for 70.3% of net sales.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock I.Ceram - Euronext Paris